ASDS 2018 Data: Skin Cancer Treatments, Cosmetic Procedures Are on the Rise

Sunday, August 25, 2019 | Fillers & Injectables , Lasers & Light Devices , Skin Cancer , American Society for Laser Medicine and Surgery , ASDS , Microneedling


American Society for Dermatologic Surgery (ASDS) member dermatologists performed more than 12.5 million medical and cosmetic procedures in 2018 – 7.5 percent more than 2017 and a 60 percent increase since 2012, according to the 2018 ASDS Survey on Dermatologic Procedures

Skin cancer treatments are the most-performed procedure with more than 3.5 million treatments performed by ASDS members. Additionally, sun damage treatments were up 29 percent this year and a striking 63 percent in just two years.

ASDS members also performed nearly nine million cosmetic treatments in 2018, a more than seven percent increase over 2017. Body sculpting saw the largest increase up 43 percent from last year with more than 623,000 treatments, injectable soft-tissue fillers and laser/light/energy-based treatments grew 78 percent and 74 percent respectively in the last seven years.

 

In 2018, ASDS members performed:

  • 3.4 million procedures using laser, light and energy-based devices
  • 2.1 million neuromodulator injections
  • 1.6 million soft-tissue filler injections
  • 623,000 body-sculpting treatments
  • 497,000 chemical peels

For body contouring procedures in 2018:

  • Deoxycholic acid rose more than 43 percent.
  • Microfocused ultrasound increased 38 percent.
  • Tumescent liposuction grew 17 percent.

For 2018, wrinkles, sun damage and facial redness lead the types of conditions treated with laser or light-based device with more than 2.2 million treatments performed.

The survey also reported that there were more than 72,000 hair rejuvenation procedures such as platelet-rich plasma (PRP). Microneedling showed a 45 percent increase compared to 2017 data, with more than 262,000 treatments performed. Thread lifts are also increasing in popularity with nearly 33,000 procedures performed.

Next Story

Comments

You must be logged in to leave a comment.